Zeltiq Aesthetics Inc  

(Public, NASDAQ:ZLTQ)   Watch this stock  
Find more results for Zeltiq Aesthetics Inc�
29.39
Dec 19 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range     -
52 week 13.30 - 30.02
Open     -
Vol / Avg. 0.00/582,171.00
Mkt cap 1.11B
P/E     -
Div/yield     -
EPS -0.16
Shares 37.85M
Beta 0.12
Inst. own 103%
Feb 23, 2015
Q4 2014 ZELTIQ Aesthetics Inc Earnings Release (Estimated) - 4:00PM EST - Add to calendar
Nov 20, 2014
ZELTIQ Aesthetics Inc at Goldman Sachs US Emerging / SMID Cap Growth Conference
Nov 20, 2014
ZELTIQ Aesthetics Inc at Canaccord Genuity Medical Technologies & Diagnostics Forum
Nov 19, 2014
ZELTIQ Aesthetics Inc at Stifel Healthcare Conference
Nov 3, 2014
ZELTIQ Aesthetics Inc at Barclays Select Series 2014: MedTech SMID Cap Day
Oct 28, 2014
Q3 2014 ZELTIQ Aesthetics Inc Earnings Call
Oct 28, 2014
Q3 2014 ZELTIQ Aesthetics Inc Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q3 (Sep '14) 2013
Net profit margin 10.47% -17.29%
Operating margin 10.87% -17.33%
EBITD margin - -15.78%
Return on average assets 21.03% -21.65%
Return on average equity 29.61% -28.57%
Employees 297 -
CDP Score - -

Address

4698 Willow Rd Ste 100
PLEASANTON, CA 94588-2806
United States - Map
+1-925-4742500 (Phone)
+1-925-4742599 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Zeltiq Aesthetics, Inc. operates as a medical device development company. It engages in the design, development, and commercialization of non-invasive procedures for the reduction of unwanted fat tissue. It develops Cryolipolysis, a technology that enables the reduction of fat tissue near nerves, muscle, and bones. The Company develops a non-invasive technology for aesthetic applications and plastic surgery. Its product is used as a skin cooling device to minimize pain and thermal injury during laser and dermatological treatments.

Officers and directors

Mark J. Foley President, Chief Executive Officer, Director
Age: 48
Bio & Compensation  - Reuters
Patrick Williams Chief Financial Officer, Senior Vice President
Age: 41
Bio & Compensation  - Reuters
Sergio Garcia-Rodriguez Senior Vice President, General Counsel and Corporate Secretary
Age: 52
Bio & Compensation  - Reuters
Keith Sullivan Senior Vice President of Worldwide Sales
Age: 56
Bio & Compensation  - Reuters
Len DeBenedictis Chief Technology Officer
Age: 73
Bio & Compensation  - Reuters
Carl H Lamm Vice President of Operations
Age: 52
Bio & Compensation  - Reuters
Mary M. Fisher Director
Age: 52
Bio & Compensation  - Reuters
D. Keith Grossman Director
Age: 54
Bio & Compensation  - Reuters
Jean M. George Independent Director
Age: 56
Bio & Compensation  - Reuters
Kevin C. O'Boyle CPA Independent Director
Age: 58
Bio & Compensation  - Reuters